,i  #aaith ,,congress  #ast ,session    
,h4 ,r4 #dchh  ,,in ,,the ,,house ,,of  
,,representatives  ,july #ae1 #bjbe,mr4 
,massie 7for himself and ,mr4 ,gosar7   
introduced the following bill2 which was
 referred to the ,committee on ,energy  
and ,commerce  ,a ,,bill  ,to repeal    
sections #cai;,f-#c and #cai;,f-#d of   
the ,public ,health ,service ,act1 and  
for other purposes4  #a4 ,short title   
,this ,act may be cited as the ,,prep   
,repeal ,act4  #b4 ,findings ,congress  
finds the following3  7#a7 ,liability   
shields granted under section #cai;,f-#c
 of the ,public ,health ,service ,act   
7#db ,u4,s4,c4 #bdg;d-#f;d7 have        
undermined public trust and             
accountability during public health     
emergencies4  7#b7 ,the ability of      
citizens to seek redress for injury or  
harm is a fundamental principle of      
justice and due process4  7#c7 ,the     
,public ,readiness and ,emergency       
,preparedness ,act 7,public ,law        
#aji-adh7 7commonly referred to as the  

,,prep ,act7 has enabled regulatory     
capture and legal immunity for          
pharmaceutical manufacturers at the     
expense of individual rights4  #c4      
,repeal of liability immunity for       
pandemic products  7a7 ,repeals ,the    
following sections are repealed3  7#a7  
,section #cai;,f-#c of the ,public      
,health ,service ,act 7#db ,u4,s4,c4    
#bdg;d-#f;d74  7#b7 ,section #cai;,f-#d 
of the ,public ,health ,service ,act    
7#db ,u4,s4,c4 #bdg;d-#f;e74  7b7       
,rescission ,the unobligated balances of
 amounts in the ,covered ,countermeasure
 ,process ,fund1 as established by      
section #cai;,f-#d7;a7 of the ,public   
,health ,service ,act 7#db ,u4,s4,c4    
#bdg;d-#f;e7a771 as in effect on the day
 before the date of enactment of this   
,act1 are rescinded4  7c7 ,references   
7#a7 ,in general ,any reference in      
,federal law to a section described in  
subsection 7a7 or a provision thereof   
shall be construed to be a reference to 
such section or provision as in effect  

on the day before the date of enactment 
of this ,act4  7#b7 ,amendment ,section 
#efe7;b77#a7 of the ,federal ,food1     
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cfj;bbb-#d7;b77#a77 is amended by     
striking #cai;,f-#c14  #d4 ,preservation
 of existing rights ,nothing in this    
,act shall be construed to limit the    
ability of any person to pursue civil   
remedies under ,federal or ,state law   
for injury or harm arising from the     
development1 administration1 or         
distribution of any--  7#a7 drug or     
device 7as such terms are defined in    
section #bja of the ,federal ,food1     
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cba772  7#b7 biological product 7as   
defined in section #cea7;i7 of the      
,public ,health ,service ,act 7#db      
,u4,s4,c4 #bfb7;i7772 or  7#c7 covered  
countermeasure 7as defined in section   
#cai;,f-#c7;i7 of the ,public ,health   
,service ,act 7#db ,u4,s4,c4            
#bdg;d-#f;d7i771 as in effect on the day
 before the date of enactment of this   

,act74  #e4 ,application ,this ,act1    
including the repeals under section     
#c7;a71 shall only apply with respect to
 actions1 claims1 or proceedings that-- 
7#a7 on the date of enactment of this   
,act1 are pending 7including actions1   
claims1 or proceedings for which a right
 of appeal has not been exhausted72 or  
7#b7 are commenced on or after such date
 of enactment4  #f4 ,severability ,if   
any provision of this ,act or the       
application thereof to any person or    
circumstance is held invalid1 the       
remainder of the ,act and the           
application of such provision to other  
persons or circumstances shall not be   
affected4